S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
NASDAQ:THRN

Thorne HealthTech (THRN) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$10.19
$10.19
50-Day Range
$10.13
$10.20
52-Week Range
$3.41
$10.20
Volume
N/A
Average Volume
110,986 shs
Market Capitalization
$549.44 million
P/E Ratio
26.82
Dividend Yield
N/A
Price Target
$8.60
THRN stock logo

About Thorne HealthTech Stock (NASDAQ:THRN)

Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to enhance and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.

THRN Stock News Headlines

Dr. Gary A. Thorne
Lisa D. Thorne
Did you make $29,000 two days with AI options trades?
What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:
Dr. Doris K. Thorne
Did you make $29,000 two days with AI options trades?
What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:
Thorne HealthTech Inc
TWOU, OTLY and LWAY among mid-day movers
Update: THRN and FREE, August 9
See More Headlines
Receive THRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Thorne HealthTech and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/10/2021
Today
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Packaged Foods
Sub-Industry
N/A
Current Symbol
NASDAQ:THRN
Fax
N/A
Employees
544
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.60
High Stock Price Target
$10.20
Low Stock Price Target
$7.00
Potential Upside/Downside
-15.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$15.67 million
Pretax Margin
5.59%

Debt

Sales & Book Value

Annual Sales
$228.73 million
Cash Flow
$0.26 per share
Book Value
$2.78 per share

Miscellaneous

Free Float
13,480,000
Market Cap
$549.44 million
Optionable
Not Optionable
Beta
0.82
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Paul F. Jacobson (Age 68)
    Co-Founder, CEO & Chairman
    Comp: $965k
  • Mr. William C. McCamy (Age 53)
    Pres
    Comp: $478.95k
  • Ms. Saloni S. Varma (Age 44)
    CFO & Director
    Comp: $75k
  • Mr. Thomas P. McKenna (Age 63)
    COO & Director
    Comp: $805.95k
  • Mr. Scott R. Hurth (Age 43)
    Chief Technology Officer
  • Dr. Nathan D. Price Ph.D. (Age 47)
    Chief Scientific Officer & CEO of Onegevity
  • Mr. Thomas Wilson
    VP & Head of Investor Relations
  • Mr. Kim R. Pearson (Age 71)
    Gen. Counsel
  • Ms. Michelle L. Crow (Age 33)
    Chief Marketing Officer
  • Mr. Rob Monteleone
    Sr. VP of Professional Sales

THRN Stock Analysis - Frequently Asked Questions

Should I buy or sell Thorne HealthTech stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Thorne HealthTech in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" THRN shares.
View THRN analyst ratings
or view top-rated stocks.

What is Thorne HealthTech's stock price target for 2024?

2 equities research analysts have issued 12-month target prices for Thorne HealthTech's shares. Their THRN share price targets range from $7.00 to $10.20. On average, they expect the company's stock price to reach $8.60 in the next twelve months. This suggests that the stock has a possible downside of 15.6%.
View analysts price targets for THRN
or view top-rated stocks among Wall Street analysts.

How were Thorne HealthTech's earnings last quarter?

Thorne HealthTech, Inc. (NASDAQ:THRN) released its quarterly earnings results on Wednesday, November, 10th. The company reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.02) by $0.03. The firm had revenue of $48.01 million for the quarter. Thorne HealthTech had a net margin of 7.84% and a trailing twelve-month return on equity of 9.03%.

When did Thorne HealthTech IPO?

Thorne HealthTech (THRN) raised $98 million in an initial public offering (IPO) on Thursday, September 23rd 2021. The company issued 7,000,000 shares at a price of $13.00-$15.00 per share.

This page (NASDAQ:THRN) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners